Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - SHORT-TERM DEBT
Short-term Debt YMAB - Y-mAbs Therapeutics, Inc.
630 K
LAST VALUE
-39.76%
2 YEAR CAGR
-9.40%
5 YEAR CAGR
0.00%
10 YEAR CAGR